Avoid the 10 costliest pharmacology mistakes in NEET PG 2026: confused DOCs, mixed-up mechanisms, missed ADR pairs, enzyme inducer/inhibitor errors, and more. Each mistake includes an example MCQ and the correct approach.
Version 1.0 — Published April 2026
The single costliest pharmacology mistake in NEET PG is confusing enzyme inducers with inhibitors — this error alone can cost you 2-3 questions per paper. To protect your 18-22 pharmacology marks:
Pharmacology contributes 18-22 questions to NEET PG, making it the highest-weighted pre/para-clinical subject (NEET PG 2021-2024 pattern analysis). Unlike anatomy or biochemistry, where questions test recall of isolated facts, pharmacology questions test your ability to distinguish between closely related drugs, mechanisms, and clinical applications. A single point of confusion — say, mixing up enzyme inducers and inhibitors — can cascade across 2-3 questions in the same paper.
The ten mistakes below are not rare errors. They are the patterns that coaching faculty across AIIMS, PGI, and private institutes report as the most frequent mark-losers in their student cohorts. Each mistake includes what students typically do, why it fails, the correct approach, and an example MCQ that demonstrates the trap.
For a comprehensive pharmacology strategy, pair this guide with the pharmacology MCQ strategy guide and the 45-day pharmacology mastery plan.
What students do: Memorize a single DOC for a condition without noting which guideline edition it comes from. When the exam updates to newer guidelines, the old DOC becomes the wrong answer.
Why it is wrong: Treatment guidelines change. The DOC for hypertension in pregnancy was historically methyldopa, and it remains the first-line for chronic hypertension in pregnancy. But for acute severe hypertension in pregnancy, the current recommendation is IV labetalol or IV hydralazine (ACOG 2020, FOGSI guidelines). Students who memorize "methyldopa = DOC for hypertension in pregnancy" without distinguishing chronic from acute lose the mark.
Correct approach: Always pair the DOC with the clinical context. Build a three-column table: Condition (with qualifier) | DOC | Source/Year. Update your list when a new standard textbook edition releases.
Example MCQ: A 32-week pregnant woman presents with BP 170/110 mmHg, headache, and blurred vision. What is the drug of choice for immediate BP control?
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Start practicing NEET PG MCQs with AI-powered explanations.
Start Free PracticeHow AI supercharges spaced repetition for NEET PG — the neuroscience of memory, Ebbinghaus forgetting curve, adaptive scheduling, and practical implementation. Compare Anki, NEETPGAI, and manual flashcards.
A structured 30-day NEET PG revision strategy with weekly breakdowns, daily schedules, subject-wise priority tables, mock test protocol, and exam-day preparation. Based on cognitive science and topper analysis.
An unbiased feature-by-feature comparison of NEETPGAI and Marrow for NEET PG 2026. Covers QBank, video lectures, pricing, AI features, mock tests, and which platform suits your preparation style.
Answer: (b). Labetalol IV is the DOC for acute severe hypertension in pregnancy. Methyldopa is for chronic management. Enalapril (ACE inhibitor) is teratogenic and absolutely contraindicated.
What students do: Assume all drugs in a class share identical mechanisms. For example, treating all beta-blockers as equivalent when they have crucial differences.
Why it is wrong: Within-class differences determine clinical choices. Propranolol (non-selective beta-blocker) blocks both B1 and B2 receptors — it is contraindicated in asthma because B2 blockade causes bronchospasm. Atenolol and metoprolol are cardioselective (B1-selective) and safer in patients with mild asthma. Carvedilol blocks alpha-1 in addition to B1 and B2, making it useful in heart failure (vasodilation). Nebivolol also produces NO-mediated vasodilation.
Correct approach: For each drug class, build a mechanism differentiation table. Focus on the clinically relevant differences that change prescribing decisions — those are the ones NBE tests.
Example MCQ: Which beta-blocker is contraindicated in bronchial asthma?
Answer: (c). Propranolol is non-selective and blocks B2 receptors in bronchial smooth muscle, causing bronchospasm. Cardioselective agents (a, b, d) are relatively safer, though not absolutely safe in severe asthma.
What students do: Study drug mechanisms in detail but skip the classic adverse drug reaction pairings. When the exam presents a clinical scenario describing an ADR and asks which drug caused it, they cannot map the symptom to the drug.
Why it is wrong: NEET PG tests 3-4 ADR questions per paper. These are pattern-recognition questions — you either know the pair or you do not. No amount of mechanism reasoning will tell you that chloramphenicol causes gray baby syndrome or that vincristine causes peripheral neuropathy.
Correct approach: Memorize ADR-drug pairs as a dedicated flashcard set. The high-yield pairs that repeat:
| Drug | Classic ADR |
|---|---|
| Chloramphenicol | Gray baby syndrome, aplastic anemia |
| Methotrexate | Pancytopenia, hepatic fibrosis, mucositis |
| Cisplatin | Nephrotoxicity, ototoxicity |
| Bleomycin | Pulmonary fibrosis |
| Doxorubicin | Cardiotoxicity (dilated cardiomyopathy) |
| Vincristine | Peripheral neuropathy |
| Cyclophosphamide | Hemorrhagic cystitis (prevent with mesna) |
| Thalidomide | Phocomelia |
| Isotretinoin | Teratogenicity (craniofacial defects) |
| Amiodarone | Thyroid dysfunction, pulmonary fibrosis, corneal microdeposits |
| Clozapine | Agranulocytosis |
| Statins | Rhabdomyolysis (rare but tested) |
Example MCQ: A patient on chemotherapy develops progressive breathlessness. HRCT shows bilateral reticular opacities. The most likely causative drug is:
Answer: (b). Bleomycin causes dose-dependent pulmonary fibrosis. Cisplatin causes nephrotoxicity and ototoxicity. Vincristine causes neuropathy. Doxorubicin causes cardiotoxicity.
Practice pharmacology MCQs with AI-powered explanations that adapt to your mistakes — the fastest way to build ADR pattern recognition.
What students do: Cannot reliably classify a given drug as a CYP450 inducer or inhibitor. This causes errors in drug interaction questions, which appear 1-2 times per paper.
Why it is wrong: Inducers increase CYP450 enzyme activity, accelerating metabolism of co-administered drugs and reducing their efficacy. Inhibitors decrease CYP450 activity, slowing metabolism and increasing toxicity risk. Getting this backward reverses the clinical prediction.
Correct approach: The inducer list is short — memorize it. The mnemonic CRAP GPS covers the major inducers:
Everything commonly tested that is not on this list is likely an inhibitor: ketoconazole, erythromycin, cimetidine, ciprofloxacin, grapefruit juice, ritonavir, isoniazid, valproate, fluconazole, chloramphenicol.
Example MCQ: A woman on oral contraceptive pills is started on rifampicin for tuberculosis. What is the expected effect on contraceptive efficacy?
Answer: (b). Rifampicin is a potent CYP450 inducer. It accelerates metabolism of ethinylestradiol in OCPs, reducing plasma levels and causing contraceptive failure. This is one of the most tested drug interactions in NEET PG.
What students do: Know that certain drugs are teratogenic but cannot match the specific drug to its characteristic fetal defect. The exam demands the specific pairing, not just "teratogenic."
Why it is wrong: NEET PG does not ask "Is drug X teratogenic?" It asks "Which drug causes Ebstein anomaly?" or "A pregnant woman on drug X has a baby with nasal hypoplasia. Which drug?" The answer requires the specific drug-defect pair.
Correct approach: Memorize the seven must-know pairs:
| Drug | Characteristic fetal defect |
|---|---|
| Thalidomide | Phocomelia (limb reduction defects) |
| Isotretinoin (vitamin A) | Craniofacial and cardiac defects |
| Warfarin | Nasal hypoplasia, stippled epiphyses (chondrodysplasia punctata) — first trimester |
| Phenytoin | Fetal hydantoin syndrome (craniofacial abnormalities, digital hypoplasia, nail hypoplasia) |
| Valproate | Neural tube defects (spina bifida) |
| Methotrexate | Neural tube defects, limb defects |
| Lithium | Ebstein anomaly (downward displacement of tricuspid valve) |
Example MCQ: A baby born to a mother on an antiepileptic drug has midface hypoplasia, short nose, and digital hypoplasia. The most likely drug is:
Answer: (b). Fetal hydantoin syndrome is caused by phenytoin. Valproate causes neural tube defects. Carbamazepine also causes neural tube defects but less commonly than valproate. Lamotrigine is considered the safest antiepileptic in pregnancy.
What students do: Remember the drug class for an infection (e.g., "fluoroquinolones for UTI") but not the specific DOC. The exam asks for the specific drug.
Why it is wrong: The DOC varies by organism, site, and patient factors. For uncomplicated UTI, the DOC is nitrofurantoin or TMP-SMX (not ciprofloxacin, which is reserved for complicated UTI). For enteric fever (typhoid), the DOC has shifted from chloramphenicol to ceftriaxone (for resistant strains) and azithromycin (for uncomplicated cases). Answering with the class instead of the specific drug loses the mark.
Correct approach: Build a condition-specific DOC table focused on infections that NBE tests repeatedly:
| Infection | DOC | Alternative |
|---|---|---|
| MRSA | Vancomycin | Linezolid, daptomycin |
| Enteric fever (uncomplicated) | Azithromycin / Cefixime | Ceftriaxone (severe) |
| Pseudomonas | Piperacillin-tazobactam / Ceftazidime | Meropenem |
| Anaerobic infections | Metronidazole | Clindamycin |
| Fungal meningitis (Crypto) | Amphotericin B + flucytosine | Fluconazole (maintenance) |
| Malaria (P. falciparum, severe) | Artesunate IV | Quinine IV |
| Kala-azar (India) | Liposomal amphotericin B | Miltefosine |
Example MCQ: A 30-year-old man with fever for 2 weeks, hepatosplenomegaly, and pancytopenia is diagnosed with kala-azar. The drug of choice in India is:
Answer: (c). Liposomal amphotericin B is the current DOC for visceral leishmaniasis in India (NVBDCP 2021 guidelines), replacing sodium stibogluconate due to resistance in Bihar.
What students do: Cannot correctly identify which drugs follow zero-order kinetics or explain the clinical significance of this distinction.
Why it is wrong: Zero-order kinetics means the elimination rate is constant regardless of concentration (the metabolic pathway is saturated). A small dose increase can cause disproportionate plasma level rise — this is why phenytoin dosing is tricky. First-order kinetics means a constant fraction is eliminated per unit time — doubling the dose doubles the steady-state level predictably.
Correct approach: Memorize the short list of clinically important zero-order drugs: phenytoin, ethanol, aspirin (at high doses), and theophylline (at toxic levels). The mnemonic PEAT helps. Everything else commonly tested follows first-order kinetics.
The clinical implication for phenytoin: once the hepatic enzymes are saturated, even a small dose increase (say, 300 mg to 400 mg) can cause a large jump in plasma levels, leading to toxicity (nystagmus, ataxia, gum hyperplasia).
Example MCQ: A patient on phenytoin 300 mg/day has a subtherapeutic level. The dose is increased to 400 mg/day. Plasma levels rise from 10 to 35 mcg/mL. This disproportionate rise is because phenytoin follows:
Answer: (b). Phenytoin follows zero-order (Michaelis-Menten) kinetics at therapeutic doses because hepatic CYP2C9/2C19 enzymes are saturated. Small dose increments cause disproportionate plasma level increases.
What students do: Focus only on the "target drug" in the stem and ignore the other medications listed. When the question is actually about a drug interaction, they miss the answer.
Why it is wrong: NEET PG increasingly presents clinical polypharmacy scenarios where the answer depends on recognizing an interaction. For example: "A patient on warfarin is started on aspirin. What is the risk?" If you focus only on warfarin's anticoagulant mechanism, you miss that the question is testing the additive bleeding risk of dual antithrombotic therapy.
Correct approach: When a stem lists two or more drugs, always ask: "Is this testing a drug interaction?" The high-yield interactions:
Example MCQ: A patient on lithium for bipolar disorder is started on hydrochlorothiazide for hypertension. What is the expected effect on lithium levels?
Answer: (b). Thiazide diuretics reduce lithium clearance by enhancing proximal tubular reabsorption of lithium (along with sodium). This increases lithium levels, risking toxicity. Loop diuretics have a lesser effect.
What students do: Treat prodrugs as active drugs and vice versa, leading to incorrect answers about mechanism and metabolism.
Why it is wrong: A prodrug is pharmacologically inactive until metabolized to its active form. If the question asks "Which is a prodrug?" and you do not know the list, you may mark an active drug. Conversely, if the stem asks about the mechanism of a prodrug, you need to know the active metabolite.
Correct approach: Know the high-yield prodrug conversions:
| Prodrug | Active form | Activating mechanism |
|---|---|---|
| Enalapril | Enalaprilat | Hepatic hydrolysis |
| Levodopa | Dopamine | DOPA decarboxylase |
| Cyclophosphamide | Phosphoramide mustard | Hepatic CYP450 |
| Azathioprine | 6-mercaptopurine | Non-enzymatic |
| Clopidogrel | Active thiol metabolite | Hepatic CYP2C19 |
| Codeine | Morphine | CYP2D6 |
| Valacyclovir | Acyclovir | Intestinal/hepatic esterases |
| Omeprazole | Sulfenamide (active) | Parietal cell H+ activation |
Example MCQ: Clopidogrel resistance is most commonly associated with polymorphism of which enzyme?
Answer: (b). Clopidogrel is a prodrug activated by CYP2C19. Poor metabolizers (CYP2C19*2 and *3 alleles) cannot convert clopidogrel to its active metabolite, resulting in reduced antiplatelet effect and clinical resistance.
What students do: Encounter an unfamiliar drug name in the stem and fail to recognize its class from the suffix, wasting time and often guessing wrong.
Why it is wrong: Drug nomenclature follows WHO INN (International Nonproprietary Name) conventions where the suffix identifies the pharmacological class. A student who does not recognize "-sartan" as an ARB or "-floxacin" as a fluoroquinolone cannot even begin to answer a question about an unfamiliar member of that class.
Correct approach: Master these suffix-class mappings:
| Suffix | Drug class | Example |
|---|---|---|
| -olol | Beta-blockers | Atenolol, metoprolol |
| -pril | ACE inhibitors | Enalapril, ramipril |
| -sartan | ARBs | Losartan, telmisartan |
| -statin | HMG-CoA reductase inhibitors | Atorvastatin, rosuvastatin |
| -dipine | Dihydropyridine CCBs | Amlodipine, nifedipine |
| -azole | Antifungals (imidazole/triazole) | Ketoconazole, fluconazole |
| -floxacin | Fluoroquinolones | Ciprofloxacin, moxifloxacin |
| -cycline | Tetracyclines | Doxycycline, minocycline |
| -mycin | Macrolides | Azithromycin, clarithromycin |
| -navir | Protease inhibitors (HIV) | Ritonavir, atazanavir |
| -vir | Antivirals | Acyclovir, oseltamivir |
| -mab | Monoclonal antibodies | Trastuzumab, rituximab |
| -nib | Tyrosine kinase inhibitors | Imatinib, erlotinib |
Example MCQ: A new antihypertensive drug "Azilsartan" is introduced. Based on its name, it most likely acts by:
Answer: (c). The "-sartan" suffix identifies azilsartan as an angiotensin II receptor blocker (ARB). Even without prior exposure to the drug name, the suffix gives the mechanism.
| Mistake | What students do | Correct approach |
|---|---|---|
| DOC confusion | Memorize one DOC per condition | Group DOC by clinical scenario + guideline year |
| Same-class mechanism mix-up | Assume all drugs in class are equivalent | Build within-class differentiation tables |
| Missing ADR pairs | Study mechanisms, skip ADRs | Dedicated ADR-drug flashcard set |
| Inducer/inhibitor confusion | Cannot classify reliably | Memorize the short inducer list (CRAP GPS); rest are inhibitors |
| Teratogen errors | Know drug is teratogenic, miss specific defect | Memorize 7 drug-defect pairs |
| DOC for infections | Remember drug class, not specific drug | Build organism-specific DOC table |
| Zero/first-order confusion | Cannot identify zero-order drugs | PEAT mnemonic; understand clinical implication |
| Missed drug interactions | Focus on single drug in polypharmacy stem | Always check for interaction when 2+ drugs listed |
| Prodrug errors | Treat prodrug as active drug | Know the prodrug-active form conversion table |
| Class ending ignorance | Cannot classify unfamiliar drug names | Master 13 suffix-class mappings |
Before your next pharmacology revision session, verify you can answer each of these without looking:
If you hesitate on more than 2 items, revisit the corresponding mistake section above.
Pharmacology contributes 18-22 questions in NEET PG (2021-2024 analysis), making it the highest-weighted pre/para-clinical subject. Of these, 6-8 questions directly test drug-of-choice, 3-4 test mechanisms, and 3-4 test adverse effects. The remaining questions are mixed stems involving clinical pharmacology scenarios. Getting even 3-4 of these wrong due to avoidable confusion costs you 10-12 marks.
Confusing enzyme inducers and inhibitors is the single costliest mistake. Students mix up which P450 inducers speed up drug metabolism (reducing efficacy) versus which inhibitors slow it down (causing toxicity). The classic trap: rifampicin is an inducer that reduces OCP efficacy, but students sometimes mark it as an inhibitor. Memorize the short list of inducers (CRAP GPS) and know that most other drugs are inhibitors.
Do not memorize DOC lists in isolation. Group them by clinical scenario: DOC for hypertensive emergency (sodium nitroprusside IV), DOC for hypertensive urgency (oral nifedipine), DOC for hypertension in pregnancy (methyldopa for chronic, labetalol/hydralazine for acute). This clinical-context grouping prevents the most common error — applying the right drug to the wrong clinical situation.
Yes, 1-2 questions on teratogenic drugs appear in most NEET PG papers. The must-know list: thalidomide (phocomelia), isotretinoin (craniofacial and cardiac defects), methotrexate (neural tube defects), warfarin (nasal hypoplasia, stippled epiphyses), phenytoin (fetal hydantoin syndrome), valproate (neural tube defects), lithium (Ebstein anomaly). Students lose marks by confusing which defect maps to which drug.
First-order kinetics means a fixed fraction of the drug is eliminated per unit time — the rate depends on concentration. Most drugs follow this pattern. Zero-order kinetics means a fixed amount is eliminated per unit time regardless of concentration — the elimination pathway is saturated. The classic zero-order drugs are phenytoin, ethanol, aspirin (at high doses), and theophylline at toxic levels. The exam tests this by asking which drug shows dose-dependent kinetics.
Drug class endings are your fastest sorting tool in pharmacology MCQs. Build a one-page reference: -olol (beta-blockers), -pril (ACE inhibitors), -sartan (ARBs), -statin (HMG-CoA reductase inhibitors), -dipine (dihydropyridine CCBs), -azole (antifungals), -floxacin (fluoroquinolones), -cycline (tetracyclines), -mycin (macrolides). The mistake is not knowing the endings — it is not using them to quickly categorize unfamiliar drug names in the stem.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Master pharmacology patterns by practicing MCQs that test these exact trap points. Start with the pharmacology subject page and work through high-yield topics systematically. Ready for unlimited AI-powered MCQs? Explore NEETPGAI Pro.
Build your personalized pharmacology study plan with the AI planner — it identifies your weak drug classes and schedules targeted revision.
Written by: NEETPGAI Editorial Team Reviewed by: Pending SME Review Last reviewed: April 2026
This article is reviewed by qualified medical professionals for clinical accuracy and exam relevance. For corrections or updates, contact the editorial team.